Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Why Moderna Stock Surged Today


Shares of Moderna (NASDAQ: MRNA) climbed 8.5% on Friday following Johnson & Johnson's (NYSE: JNJ) disappointing coronavirus vaccine news.

Johnson & Johnson said that interim data from the phase 3 trial of its single-dose vaccine candidate had shown it to be 66% effective at preventing moderate to severe cases of COVID-19. However, the level of protection was lower in areas where new strains of the coronavirus are more prevalent, suggesting that it could be less effective at protecting against them.

Moderna's stock price rose sharply on Friday. Image source: Getty Images.

Continue reading


Source Fool.com

Like: 0
Share

Comments